Literature DB >> 26686246

Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.

M Klinger1, J Zheng1, K S J Elenitoba-Johnson2, S L Perkins3, M Faham1, D W Bahler3.   

Abstract

Chronic lymphocytic leukemia (CLL) develops from CLL-like monoclonal B-cell lymphocytosis (MBL) which represents a low-level asymptomatic expansion of cells that phenotypically resemble CLL. Although antigen selection plays a key role during CLL development, it is not known whether this occurs in early MBL or only during progression to CLL. Recent studies suggested that MBL sometimes displays oligoclonality, but these used techniques with limited sensitivity and specificity and were not conclusive. In this study, we combine cell sorting and next-generation sequencing of rearranged immunoglobulin heavy chain variable (IgVH) genes to thoroughly assess the VH repertoire and oligoclonality of purified MBL cells. Clonal functional rearrangements or clonotypes were identified in 29 of 30 sequenced cases, with 7 or 24% having two clonotypes with unrelated CDR3 sequences. In four of the seven cases with unrelated clonotypes, VH segments from the same family were used. In addition, 6 of 29 cases showed clear evidence of ongoing VH gene hypermutation with three of these being among the seven with unrelated clonotypes. This study conclusively shows that MBL cases often contain multiple B-cell clones, the first to report ongoing VH gene mutation in MBL, and that antigen selection appears to occur in early MBL.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26686246     DOI: 10.1038/leu.2015.351

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  24 in total

1.  B-cell clones as early markers for chronic lymphocytic leukemia.

Authors:  Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard B Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 2.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.

Authors:  T D Shanafelt; P Ghia; M C Lanasa; O Landgren; A C Rawstron
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

3.  B-cell receptor signaling in chronic lymphocytic leukemia.

Authors:  Freda K Stevenson; Sergey Krysov; Andrew J Davies; Andrew J Steele; Graham Packham
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

Review 4.  Molecular pathogenesis of chronic lymphocytic leukemia.

Authors:  Gianluca Gaidano; Robin Foà; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 5.  CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?

Authors:  Lydia Scarfò; Antonis Dagklis; Cristina Scielzo; Claudia Fazi; Paolo Ghia
Journal:  Semin Cancer Biol       Date:  2010-09-15       Impact factor: 15.707

6.  Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

Authors:  Natali Pflug; Jasmin Bahlo; Tait D Shanafelt; Barbara F Eichhorst; Manuela A Bergmann; Thomas Elter; Kathrin Bauer; Gebhart Malchau; Kari G Rabe; Stephan Stilgenbauer; Hartmut Döhner; Ulrich Jäger; Michael J Eckart; Georg Hopfinger; Raymonde Busch; Anna-Maria Fink; Clemens-Martin Wendtner; Kirsten Fischer; Neil E Kay; Michael Hallek
Journal:  Blood       Date:  2014-05-05       Impact factor: 22.113

7.  Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.

Authors:  M Ryan Corces-Zimmerman; Wan-Jen Hong; Irving L Weissman; Bruno C Medeiros; Ravindra Majeti
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

8.  Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.

Authors:  Malek Faham; Jianbiao Zheng; Martin Moorhead; Victoria E H Carlton; Patricia Stow; Elaine Coustan-Smith; Ching-Hon Pui; Dario Campana
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

9.  The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.

Authors:  Antonis Dagklis; Claudia Fazi; Cinzia Sala; Valeria Cantarelli; Cristina Scielzo; Roberto Massacane; Daniela Toniolo; Federico Caligaris-Cappio; Kostas Stamatopoulos; Paolo Ghia
Journal:  Blood       Date:  2008-11-24       Impact factor: 22.113

10.  Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.

Authors:  M C Lanasa; S D Allgood; A D Volkheimer; J P Gockerman; J F Whitesides; B K Goodman; J O Moore; J B Weinberg; M C Levesque
Journal:  Leukemia       Date:  2009-10-15       Impact factor: 11.528

View more
  9 in total

1.  Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.

Authors:  B Stamatopoulos; A Timbs; D Bruce; T Smith; R Clifford; P Robbe; A Burns; D V Vavoulis; L Lopez; P Antoniou; J Mason; H Dreau; A Schuh
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528

2.  Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL.

Authors:  K Brazdilova; K Plevova; H Skuhrova Francova; H Kockova; M Borsky; V Bikos; J Malcikova; A Oltova; J Kotaskova; B Tichy; Y Brychtova; J Mayer; M Doubek; S Pospisilova
Journal:  Leukemia       Date:  2017-08-29       Impact factor: 11.528

3.  The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.

Authors:  Clémentine Sarkozy; Sarah Huet; Victoria E H Carlton; Bettina Fabiani; Alain Delmer; Fabrice Jardin; Marie-Helene Delfau-Larue; Maya Hacini; Vincent Ribrag; Stéphanie Guidez; Malek Faham; Gilles Salles
Journal:  Oncotarget       Date:  2017-01-31

Review 4.  Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Authors:  Walaa Darwiche; Brigitte Gubler; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

5.  Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights.

Authors:  Chiara Salvetti; Candida Vitale; Valentina Griggio; Daniela Drandi; Rebecca Jones; Lisa Bonello; Riccardo Bomben; Alberto Bragoni; Davide Bagnara; Franco Fais; Valter Gattei; Federica Cavallo; Alberto Zamò; Marta Coscia
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

Review 6.  Pathophysiology of chronic lymphocytic leukemia and human B1 cell development.

Authors:  Yoshikane Kikushige
Journal:  Int J Hematol       Date:  2019-12-03       Impact factor: 2.319

7.  Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients.

Authors:  S Mimmi; E Vecchio; E Iaccino; M Rossi; A Lupia; F Albano; F Chiurazzi; G Fiume; A Pisano; S Ceglia; M Pontoriero; G Golino; P Tassone; I Quinto; G Scala; C Palmieri
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

8.  Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Authors:  Kar-Tong Tan; Ling-Wen Ding; Qiao-Yang Sun; Zhen-Tang Lao; Wenwen Chien; Xi Ren; Jin-Fen Xiao; Xin Yi Loh; Liang Xu; Michael Lill; Anand Mayakonda; De-Chen Lin; Henry Yang; H Phillip Koeffler
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

Review 9.  Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies.

Authors:  Yoshikane Kikushige
Journal:  J Clin Exp Hematop       Date:  2020-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.